Large study of dietary habits suggests more plant oils, less butter could lead to better health
Peer-Reviewed Publication
Updates every hour. Last Updated: 7-May-2025 13:10 ET (7-May-2025 17:10 GMT/UTC)
Mass General Brigham-led researchers investigated data from over 200,000 individuals who were followed for more than 30 years, and found that higher intake of plant-based oils, especially soybean, canola, and olive oil, was associated with lower total, cancer, and cardiovascular disease mortality, whereas butter intake was associated with increased risk of total and cancer mortality. The researchers also found that less than a tablespoon of butter per day with equivalent calories of plant-based oils could lower cancer deaths and overall mortality by 17%.
Chemotherapy and immunotherapy followed by de-escalated chemoradiation showed increased survival and reduced side effects in aggressive head and neck cancers that are not associated with human papillomavirus (HPV) infection, according to a new study.
More than 120 million Americans suffer from diabetes or pre-diabetes. Triple-negative breast cancer (TNBC) is the most aggressive form of breast cancer, and TNBC patients with obesity-driven diabetes often have worse outcomes.
A new study by researchers from Boston University Chobanian & Avedisian School of Medicine helps explain why this happens and suggests a potential way to improve treatment for these patients.
The researchers' new method, called chemical tomography, provides insights into tissue function by analyzing volatile organic compounds (VOCs). These molecules are present in exhaled breath, saliva, sweat, and other bodily fluids. Prof. Haick is a leading global expert in the use of VOCs for early disease detection. His prior research has led to the development of multiple diagnostic technologies based on VOC analysis.
In this study, VOC monitoring enabled the dynamic molecular and functional mapping of a human breast tissue organoid, revealing key protein and genomic data associated with the transformation of healthy breast tissue into cancerous tissue.
The system detects VOCs using a graphene-based sensor array, with the collected data analyzed through generative artificial intelligence (AI). The inspiration for this technology comes from the compound eye of insects – a structure composed of multiple small eyes that send numerous images to the insect’s brain for analysis. In the system, the graphene sensors function as the compound eye, while AI acts as the brain, processing and interpreting the data.
BRCA1 and BRCA2 genes play a crucial role in repairing damaged DNA. Mutations in BRCA1 and BRCA2 substantially increase the likelihood of breast and ovarian cancer, respectively. This new research illustrates how small breaks in one strand of DNA can expand into a large single-stranded DNA gap that kills drug-resistant breast BRCA mutant cancer cells. The novel vulnerability in mutant BRCA1 and BRCA2 may be a potential target for new therapeutics.
Cancer and cardiovascular diseases (CVDs) share common risk factors, and treatments for cancer have the potential to increase the risk of CVDs. Researchers have elaborated on the importance of recognizing the indicators, patterns, predictive outcomes, and challenges associated with CVD risks in cancer patients and survivors. Proactive management and early detection are essential to improving the overall health outcomes and quality of life for patients with cancer.
Researchers from SRM Institute of Science and Technology, led by Dr. KN Aruljothi, have published a study in ExRNA highlighting the role of exosomal RNA (exRNA) in head and neck cancers (HNCs). Exosomal RNAs, including miRNA, mRNA, and lncRNA, are secreted by tumor cells and play a pivotal role in cancer progression by modulating key signaling pathways such as NF-κB, EGFR, and PI3K/AKT/mTOR. These exRNAs influence the tumor microenvironment, promote metastasis, and contribute to immune evasion and therapy resistance. The study underscores the potential of exRNA-based liquid biopsy through saliva and blood samples for early diagnosis and treatment monitoring, presenting a promising avenue for precision oncology in HNC management.
Cancer treatment has advanced significantly, focusing on targeted approaches that destroy tumor cells while sparing healthy tissue. Researchers at JAIST have developed magnetic nanoparticles that can be directed to tumors using a magnet and then heated with a laser to destroy cancer cells. In mouse models, this targeted technique successfully eliminated tumors entirely. This innovative method provides a more precise and less toxic alternative to traditional treatments, paving the way for more effective cancer therapies.
A new paper in the Journal of Breast Imaging indicates that breast cancer mortality rates have stopped declining in women older than age 74, and reconfirms that breast cancer mortality rates have stopped falling in women younger than age 40. This finding for older women is new.